BioSmartData contributes to a national consensus on chronic pain published in the Journal of Pain Research

The study establishes a standardized set of clinical variables to assess chronic pain patients, promoting the generation of real-world evidence in healthcare.

Chronic pain affects millions of people worldwide and remains one of the most complex challenges in modern medicine. Its clinical diversity and impact on patients’ quality of life demand approaches based on reliable and comparable data. With this goal, a multidisciplinary group of pain specialists from across Spain developed a national consensus defining the Optimal Information for Chronic Pain (OICP).

The results have been published in the Journal of Pain Research (2025) under the title:
“Optimal Information for Chronic Pain (OICP): Delphi Consensus on Patient Assessment and Interventional Techniques.”

The study identifies key clinical variables essential for the evaluation and follow-up of chronic pain patients, covering areas such as medical history, treatments applied, and symptom progression. This standardization will help improve the quality and consistency of clinical data and foster the use of Real-World Evidence (RWE) to support medical decision-making.

BioSmartData’s role

BioSmartData contributed to the project through the technical deployment of the Delphi platform and the coordination of survey dissemination, ensuring data quality and consistency throughout the process. This technological collaboration was key to enabling the participation of more than 50 experts from different specialties and hospitals across Spain.

“Transforming data into real clinical knowledge is one of the pillars of BioSmartData. This project demonstrates the power of collaboration between science and technology to generate meaningful evidence that improves patient care.” — BioSmartData Team

📖 View full publication

A milestone for BioSmartData’s mission

This achievement represents a major milestone in BioSmartData’s mission: transforming clinical data into actionable knowledge that drives a more precise, human, and evidence-based medicine.

About the publication

Journal: Journal of Pain Research (2025)
Title: Optimal Information for Chronic Pain (OICP): Delphi Consensus on Patient Assessment and Interventional Techniques
Authors: Frutos V, Delgado D, Cuñat T, Aguilar JL, Recasens-Urbez J, Homs M, Fernandez-Bravo A, Izquierdo RM, Munoz-Ortego J, Sánchez M, Cordero-García C, Abejón D, Cayuela M
DOI: https://doi.org/10.2147/JPR.S548388

Co-funding

This project has been co-funded by the European Regional Development Fund (ERDF/FEDER) and the Sustainable Tourism Tax of the Balearic Islands (ITS), within the Illes Sostenibles program.
“A way to make Europe.”

Duration: 2023–2025
Reference: GOIB-PINEM23 · PINEM23_019
Beneficiary Entity: BioSmartData S.L.

El sistema sanitario debe aprender de los pacientes con dolor crónico

La healthtech mallorquina BioSmartData anuncia el lanzamiento de la segunda fase del proyecto BSD Pain Impact, un programa de investigación basado Real World Evidence en dolor crónico orientado a responder...

BioSmartData Becomes One of the First Spanish Startups to Achieve ENS ALTA Certification

BioSmartData (BSD) has obtained the National Security Framework (ENS) certification in the High category, issued by AENOR, making it one of the first emerging companies in the country to achieve...

BioSmartData: Revolucionando la Medicina con Inteligencia Artificial

El 27 de agosto, Juan Cifre, COO de BioSmartData, compartió en el programa Al día de IB3tv cómo esta startup mallorquina está transformando el sector sanitario mediante la inteligencia artificial...

BSD Clinic Professional

Ideal para clínicas que quieren participar en estudios y además contar con un sistema completo de registro, seguimiento y métricas.

150€ / mes

BSD Study Starter

Estudio de impacto activo y validado. Ideal para clínicas y médicos que quieren empezar rápido.

25€ / mes